EANM'26 Annual Congress - European Association of Nuclear Medicine
WuXi AppTec is pleased to exhibit at the EANM’26 Annual Congress, taking place October 17–21, 2026, in Vienna, Austria. As nuclear medicine continues to expand across diagnostic imaging and targeted radiopharmaceutical therapies, successful programs require coordinated expertise across radiochemistry, biology, molecular imaging, pharmacology, and preclinical development.
WuXi AppTec provides integrated capabilities to support radiopharmaceutical programs from early discovery through IND-enabling development. Our services include radiolabeling, molecular imaging, in vitro and in vivo biology, pharmacokinetics, biodistribution, bioanalysis, dosimetry, and preclinical safety assessment. Through PET/CT imaging and other radiolabeled study platforms, our teams can help characterize target engagement, tissue distribution, pharmacokinetics, therapeutic activity, and radiation exposure to support candidate selection and development decisions.
By bringing together chemistry, biology, and preclinical expertise, WuXi AppTec helps partners address the specialized challenges of developing radiopharmaceuticals and other nuclear medicine approaches while generating the data needed to advance programs toward the clinic.
Visit WuXi AppTec at Booth 333 to meet our Biology, RCS, and STA teams and discuss how our integrated capabilities can support your nuclear medicine and radiopharmaceutical development programs.
To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
WuXi AppTec Biology Services
Resource Type: Brochure
Research Chemistry Services
Resource Type: Brochure
